The Microcap Newsletter
  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference
Free Sign Up
Attend The Microcap Conference
No Result
View All Result
The Microcap Newsletter
  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference
Free Sign Up
Attend The Microcap Conference
No Result
View All Result
The Microcap Newsletter
No Result
View All Result

Supreme Court to Hear SEC v. Jarkesy in Case that Could Constrain Agency’s Enforcement Powers

November 27, 2023

The US Supreme Court will hear a landmark case this week that could dramatically alter the SEC’s enforcement powers and have sweeping implications for other federal regulatory agencies.

The Court is being asked to decide whether statutory provisions that empower the Securities and Exchange Commission to initiate and adjudicate administrative enforcement proceedings seeking civil penalties violate the Seventh Amendment, which covers a defendant’s right to a jury trial. The case also revolves around whether statutory provisions that authorize the SEC to choose to enforce the securities laws through an agency adjudication instead of filing a district court action violate the nondelegation doctrine, and whether Congress violated Article II by granting for-cause removal protection to administrative law judges in agencies whose heads enjoy for-cause removal protection.

The case involves Houston-based hedge fund manager George Jarkesy, who in March 2013 was accused by the SEC of civil charges of fraud. The charges alleged that Jarkesy and Thomas Belesis of John Thomas Financial (since renamed Patriot28 LLC) defrauded investors in two hedge funds. According to the complaint, Jarkesy told investors that he was the fund manager, when in fact a number of decisions were made by Belesis. Additionally, investors were led to believe the funds were audited by KPMG when they were not.

According to the SEC’s order, Jarkesy used fund assets to hire multiple stock promoters in 2010 and 2011 to create an artificial and unsustainable spike in the price of two microcap stocks in which the funds were heavily invested. As a result of these efforts, the funds recorded temporary gains in the value of the microcap stocks that Jarkesy used to mask the write-down of other more illiquid holdings of the funds.

Jarkesy was found guilty in an SEC administrative proceeding adjudicated by an administrative law judge. However, the hedge fund manager won a later challenge to that process in federal court, arguing that the Seventh Amendment guaranteed his right to a jury trial.

The SEC challenged that ruling, arguing that the right to a jury trial is limited for civil actions and that Congress did not make a mistake in setting up the agency with authority to conduct administrative proceedings. But defendants, including Jarkesy, argue that administrative proceedings are tilted in favor of the federal agencies.

Under the current composition of the Supreme Court, most of the justices have indicated their intent to curtail agency power. The pending case before them is one of several challenging the power of federal regulatory agencies. The Court is also evaluating the power of the Consumer Financial Protection Bureau and whether to eliminate a provision that requires judges to defer to agencies’ interpretations of administrative rules.

Meanwhile, The US Chamber of Commerce, Business Roundtable and other groups last month filed an amicus brief, asking the court to curb the overreach of a vast “administrative state.” Prominent executives and investors, including Elon Musk and Mark Cuban, have also chimed in, saying that the SEC’s in-house administrative processes “lead to unequal and unjust results.”

Arguments begin Nov. 29 before the high court. A decision is expected before the end of the term in June. Read more.

Recent Posts

Bi-Monthly Report on SEC Oversight of Penny Stock Violations

SEC: Unregistered Dealer Profits from Distressed Penny-Stock Sales

March 11, 2024
Microcap IPO Flow Remains Strong into September

Microcap IPO Flow Holds Steady into Mid-March

March 11, 2024
Cocrystal Pharma CEO Offers Look at Clinical Development and 2024 Value Catalysts

Cocrystal Pharma CEO Offers Look at Clinical Development and 2024 Value Catalysts

March 11, 2024
DealFlow Events logo

PO Box 122
Syosset, NY 11791
(516) 876-8006
team@dealflowevents.com

Twitter

Subscribe to our free newsletter

Stay informed on the latest weekly Microcap news.

SIGN UP

Sponsored content, this is a paid promotion

Comments and opinions presented in DealFlow Events publications such as The Microcap Newsletter are solely those of the analysts, corporate executives, and others quoted. They do not represent the opinions of DealFlow Events and DealFlow Events makes no recommendations on whether to buy, sell or hold shares of any particular stock. Investors are advised to conduct their own research before making an investment decision. Neither DealFlow Events nor any of its affiliates hold any position in the stocks mentioned in The Microcap Newsletter.

© DealFlow Financial Products, Inc. (d/b/a DealFlow Events). All rights reserved. DealFlow Events™ and The Microcap Conference™ and The Microcap Newsletter™ are trademarks of DealFlow Financial Products, Inc.

  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference